Cargo Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US14179K1016
USD
4.47
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

0

Shareholding (Mar 2025)

FII

14.14%

Held by 60 FIIs

DII

26.82%

Held by 34 DIIs

Promoter

30.93%

How big is Cargo Therapeutics, Inc.?

22-Jun-2025

As of Jun 18, Cargo Therapeutics, Inc. has a market capitalization of 201.52 million and reported net sales of 0.00 million with a net profit of -216.20 million over the latest four quarters. Shareholder's funds are at 360.23 million and total assets at 414.05 million as of Dec 24.

As of Jun 18, Cargo Therapeutics, Inc. has a market capitalization of 201.52 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -216.20 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 360.23 million and Total Assets at 414.05 million.

Read More

What does Cargo Therapeutics, Inc. do?

22-Jun-2025

Cargo Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting a recent net profit loss of $84 million and a market cap of $201.52 million. Key metrics include a negative P/E ratio, no dividend yield, and a return on equity of -60.15%.

Overview:<BR>Cargo Therapeutics, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: -84 Million (Quarterly Results - Mar 2025)<BR>Market cap: USD 201.52 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making)<BR>Industry P/E: NA<BR>Dividend Yield: 0.00%<BR>Debt Equity: -1.12<BR>Return on Equity: -60.15%<BR>Price to Book: 0.71<BR><BR>Contact Details:<BR>Details: No Company Details Available<BR>Registrar Address: Not available.

Read More

Is Cargo Therapeutics, Inc. technically bullish or bearish?

20-Sep-2025

As of August 5, 2025, Cargo Therapeutics, Inc. is in a mildly bearish trend, supported by bearish weekly RSI and moving averages, despite some mildly bullish indicators, and has underperformed the S&P 500 with a year-to-date return of -69.0%.

As of 5 August 2025, the technical trend for Cargo Therapeutics, Inc. has changed from sideways to mildly bearish. The current stance is bearish, with key indicators supporting this view including a weekly RSI that is bearish, daily moving averages that are mildly bearish, and Dow Theory indicating bearish trends on both weekly and monthly time frames. Although the weekly MACD and KST are mildly bullish, the overall sentiment remains bearish. The stock has significantly underperformed against the S&P 500, with a year-to-date return of -69.0% compared to the S&P 500's 12.22%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 206 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.06

stock-summary
Return on Equity

-58.23%

stock-summary
Price to Book

0.87

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-50 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.02%
0%
9.02%
6 Months
21.14%
0%
21.14%
1 Year
-73.94%
0%
-73.94%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Cargo Therapeutics, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-408.40%
EBIT to Interest (avg)
-133.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.12
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.78
EV to EBIT
0.52
EV to EBITDA
0.53
EV to Capital Employed
2.87
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
556.98%
ROE (Latest)
-60.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
Bearish
Bullish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 31 Schemes (28.11%)

Foreign Institutions

Held by 60 Foreign Institutions (14.14%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Cargo Therapeutics, Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -70.74% vs -139.27% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-180.30",
          "val2": "-93.00",
          "chgp": "-93.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "1.60",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-4.60",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-167.50",
          "val2": "-98.10",
          "chgp": "-70.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-180.30
-93.00
-93.87%
Interest
0.00
1.60
-100.00%
Exceptional Items
0.00
-4.60
100.00%
Consolidate Net Profit
-167.50
-98.10
-70.74%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -70.74% vs -139.27% in Dec 2023

stock-summaryCompany CV
About Cargo Therapeutics, Inc. stock-summary
stock-summary
Cargo Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available